Mankind Pharma shares extend gain on CCI nod for BSV acquisition
The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.
bharat serums and vaccines
October 2024
July 2024
January 2022
Mankind Pharma buys 100% stake in BSV for ₹13,630 cr
The move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian women's health and fertility drug market.
Bharat Serums to develop vaccine for Covid-19
The company’s effort to find a new method to treat Covid-19 patients comes at a time when India is in the midst of a third wave of infection.
